Atypical Antipsychotic-Induced Diabetes MellitusHow Strong is the Evidence?

被引：0
|
作者：
David C. Henderson
机构：
[1] Massachusetts General Hospital and Harvard Medical School,Psychotic Disorders and Schizophrenia Research Program
来源：
CNS Drugs | 2002年 / 16卷
关键词：
Schizophrenia; Clozapine; Risperidone; Olanzapine; Quetiapine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Atypical antipsychotics offer significant improvements over older, conventional antipsychotic agents. However, recently the newer agents have been linked to medical morbidity including hyperglycaemia, diabetes mellitus, bodyweight gain and abnormal lipid levels. Even more concerning, because of a significant risk of death, there have been numerous case reports of patients treated with clozapine or olanzapine developing diabetic ketoacidosis shortly after initiation of the drug.
引用
收藏
页码：77 / 89
页数：12
相关论文
共 50 条
  • [1] Atypical Antipsychotic-Induced Diabetes Mellitus in Child and Adolescent Psychiatry
    Dan Cohen
    Saskia Huinink
    CNS Drugs, 2007, 21 : 1035 - 1038
  • [2] Atypical Antipsychotic-Induced Metabolic Disturbances in the Elderly
    Melanie Dawn Guenette
    Araba Chintoh
    Gary Remington
    Margaret Hahn
    Drugs & Aging, 2014, 31 : 159 - 184
  • [3] Pharmacological Management of Atypical Antipsychotic-Induced Weight Gain
    Trino Baptista
    Yamily ElFakih
    Euderruh Uzcátegui
    Ignacio Sandia
    Eduardo Tálamo
    Enma Araujo de Baptista
    Serge Beaulieu
    CNS Drugs, 2008, 22 : 477 - 495
  • [4] Atypical Antipsychotic-Induced Weight GainInsights into Mechanisms of Action
    James L. Roerig
    Kristine J. Steffen
    James E. Mitchell
    CNS Drugs, 2011, 25 : 1035 - 1059
  • [5] Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents.
    Henderson D.C.
    Current Diabetes Reports, 2002, 2 (2) : 135 - 140
  • [6] Antipsychotic-Induced Venous ThromboembolismA Review of the Evidence
    Staffan Hägg
    Olav Spigset
    CNS Drugs, 2002, 16 : 765 - 776
  • [7] Atypical antipsychotic-induced akathisia with depression: Therapeutic role of mirtazapine
    Ranjan, S
    Chandra, PS
    Chaturvedi, SK
    Prabhu, SC
    Gupta, A
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (04) : 771 - 774
  • [8] The 'boon and bane' of antipsychotic-induced metabolic syndrome
    Venkatasubramanian, G.
    ACTA PSYCHIATRICA SCANDINAVICA, 2009, 120 (06) : 500 - 501
  • [9] Antipsychotic-Induced Movement Disorders in the ElderlyEpidemiology and Treatment Recommendations
    Michael P. Caligiuri
    Dilip V. Jeste
    Jonathan P. Lacro
    Drugs & Aging, 2000, 17 : 363 - 384
  • [10] Antipsychotic-Induced Hyperprolactinemia
    Bostwick, Jolene R.
    Guthrie, Sally K.
    Ellingrod, Vicki L.
    PHARMACOTHERAPY, 2009, 29 (01): : 64 - 73
12345